{"id":"NCT05170061","sponsor":"State University of New York at Buffalo","briefTitle":"24 Hour Ambulatory Cardiac Oxygen Consumption","officialTitle":"Ambulatory 24-Hour Cardiac Oxygen Consumption and Blood Pressure-Heart Rate Variability: Effects of Nebivolol and Valsartan Alone and in Combination","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02","primaryCompletion":"2014-09","completion":"2014-12","firstPosted":"2021-12-27","resultsPosted":"2025-06-08","lastUpdate":"2025-06-08"},"enrollment":26,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Nebivolol","otherNames":["Bystolic"]},{"type":"DRUG","name":"Valsartan","otherNames":["Diovan"]},{"type":"DRUG","name":"Nebivolol/valsartan combination","otherNames":["Diovan/Bystolic"]}],"arms":[{"label":"Sequence 1: Nebivolol first, then valsartan, then combination of nebivolol/valsartan","type":"ACTIVE_COMPARATOR"},{"label":"Sequence 2: Nebivolol first, then combination of nebivolol/valsartan; then valsartan","type":"ACTIVE_COMPARATOR"},{"label":"Sequence 3: Valsartan first, then Nebivolol, then combination of nebivolol/valsartan,","type":"ACTIVE_COMPARATOR"},{"label":"Sequence 4: Valsartan first, then combination of nebivolol/valsartan, then Nebivolol,","type":"ACTIVE_COMPARATOR"},{"label":"Sequence 5: Combination of nebivolol/valsartan first, then Nebivolol, then Valsartan,","type":"ACTIVE_COMPARATOR"},{"label":"Sequence 6: Combination of nebivolol/valsartan first, then Valsartan, then Nebivolol, ,","type":"ACTIVE_COMPARATOR"}],"summary":"A randomized,double-blind, active controlled,15 week study to evaluate the effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory cardiac work and variability of heart rate-mean central systolic pressure product.","primaryOutcome":{"measure":"ACRPP: 24-hour Ambulatory Central Rate-pressure Product (Also Called TTI, CTTI)","timeFrame":"measurement after 4 weeks in each treatment arm","effectByArm":[{"arm":"Nebivolol","deltaMin":2531,"sd":400},{"arm":"Valsartan","deltaMin":2824,"sd":530},{"arm":"Nebivolol/Valsartan","deltaMin":2484,"sd":368}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26116459"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":26},"commonTop":[]}}